Back to Search Start Over

059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis.

Authors :
Vollenhoven, R van
Takeuchi, T
Pangan, A L
Friedman, A
Mohamed, M F
Chen, S
Rischmueller, M
Blanco, R
Xavier, R M
Strand, V
Source :
Rheumatology; 2019 Supplement, Vol. 58, pN.PAG-N.PAG, 1p
Publication Year :
2019

Details

Language :
English
ISSN :
14620324
Volume :
58
Database :
Complementary Index
Journal :
Rheumatology
Publication Type :
Academic Journal
Accession number :
135886973
Full Text :
https://doi.org/10.1093/rheumatology/kez106.058